Snoring Control Device Market Size was valued at USD 0.35 Billion in 2022. The Snoring Control Device market industry is projected to grow from USD 0.39 Billion in 2023 to USD 0.84 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 10.20% during the forecast period (2023 - 2032).A greater understanding of how snoring affects people's health generally and the quality of their sleep, an increase in the frequency of sleep problems and snoring are the key market drivers accelerating market expansion.Â
Source: Primary Research, Secondary Research, MRFR Database and Analyst Review
Market CAGR for snoring control device is being driven by the increase in snoring and other sleep difficulties. The main causes of snoring are resistance and airway turbulence. The muscles keep the higher airway open during REM or dream sleep, when they are most relaxed. The constriction of the airway causes increased air turbulence, which causes the soft tissues in the back of the neck to vibrate. The term "anti-snoring treatment devices" refers to a variety of tools used to stop snoring, such as nasal devices, mandibular advancement devices (MAD), tongue stabilizing devices (TSD), and continuous positive airway pressure (CPAP) devices.
Additionally, the market for anti-snoring devices is increasing due to raised consumer awareness of the negative effects that snoring has on both sleep quality and general health. To spread the word about snoring and the potential health dangers it poses, numerous public health campaigns have been developed. Through these programs, the general public will be made aware of the significance of tackling snoring as a serious sleep-related problem. Institutions like the American Academy of Sleep Medicine (AASM) and the British Snoring & Sleep Apnea Association (BSSAA), for instance, have carried out awareness efforts using internet tools, social media campaigns, and neighborhood activities. Additionally, the National Stop Snoring Week is a public awareness effort aimed at informing people about snoring and how it affects their ability to have a good night's sleep. Every year, a campaign is held in the UK to promote snoring awareness, disseminate knowledge, and motivate people to find snoring treatments.
The market's expansion is fueled by the appearance of sophisticated anti-snoring devices with improved performance. Additionally, user-friendly characteristics in anti-snoring devices, such as simple adjustment mechanisms or less assembly, increase their usability for users and, as a result, support market expansion. Due to the increased prevalence of snoring, the adoption of cutting-edge anti-snoring devices, and the accessibility of these devices, developed nations like the United States, Canada, and Germany are predicted to lead the growth of the anti-snoring device market. Furthermore, because of the introduction of new medical technology, an increase in the demand for better healthcare services, and an increase in the population of elderly people who are more prone to snoring, the healthcare sector in emerging nations is growing at a large rate.
For instance, according to estimates from the Sleep Foundation, between 50 and 70 million Americans struggle with sleep disturbances. As a result, there is a growing need for efficient anti-snoring equipment, such as CPAP machines and mandibular advancement devices (MADs), to manage OSA and lessen snoring as the prevalence of sleep apnea rises. Thus, result in driving the Snoring Control Device market revenue.
The Snoring Control Device market segmentation, based on type includes Oral Appliances/Mouthpieces, Nasal Devices, Tongue-Stabilizing Devices (TSDs), Epap Therapy Devices, Position Control Devices, and Chin Straps. The oral appliances/mouthpieces segment dominated the market in the year 2022. As well as the introduction of technologically improved items, dental appliances and mouthpieces are becoming more and more popular among dentists and patients. When compared to other anti-snoring devices, oral appliances/mouthpieces have a greater acceptance rate because they are also advised as the first line of treatment.
 The Snoring Control Device market segmentation, based on distribution channel, includes Retail Pharmacies, and Online Stores. The online stores category generated the most income in 2022. Since snoring is an uncomfortable condition and people want to find relief without letting many people know, the internet stores are the ideal option for them due to the rise in the number of individuals seeking snoring relief based from home due to comfort and convenience.
Figure1: Snoring Control Device Market, by Distribution channel, 2022&2032 (USD Billion)
Source: Primary Research, Secondary Research, MRFR Database and Analyst Review
By region, the study provides the market insights into North America, Europe, Asia-Pacific and Rest of the World. The North American Snoring Control Device market area will dominate this market, a high prevalence of snoring and a sizable elderly population in the area has fuelled demand for anti-snoring equipment. The market for anti-snoring devices is expanding as a result of this rising demand.
Further, the major countries studied in the market report are The US, Germany, Canada, France, the United Kingdom, Italy, Spain, Australia, South Korea, and Brazil.
Figure2: SNORING CONTROL DEVICE MARKET SHARE BY REGION 2022 (USD Billion)Â
Source: Primary Research, Secondary Research, MRFR Database and Analyst Review
Europe Snoring Control Device market accounts for the second-largest market share due increased public awareness of the negative effects of snoring, a growing elderly and obese population, the existence of a population pool with a snoring disorder, and rising alcohol and cigarette use are all contributing factors. Further, the German Snoring Control Device market held the largest market share, and the UK Snoring Control Device market was the fastest growing market in the European region
The Asia-Pacific Snoring Control Device Market is the world's market is expected to continue to grow at a CAGR of 10.20% from 2023 to 2032.. This is due to an increase in the number of snorers in this region; anti-snoring gadget usage has increased. Additionally, the rising prevalence of obesity, alterations in lifestyle, and an increase in the number of smokers all contribute to snoring in this area. Moreover, China’s Snoring Control Device market held the largest market share, and the Indian Snoring Control Device market was the fastest growing market in the Asia-Pacific region.
Snoring Control Device Key Market Players& Competitive Insights
Leading market players are investing heavily in research and development in order to expand their product lines, which will help the Snoring Control Device market, grow even more. Additionally, market participants are engaging in a range of strategic initiatives to increase their worldwide reach, with important market developments such as the introduction of new products, contracts, mergers and acquisitions, increased investments, and cooperation with other organizations. To grow and endure in an increasingly competitive and challenging market environment, Snoring Control Deviceindustry must offer cost-effective items.
One of the main business strategies employed by manufacturers is to produce locally to reduce operational expenses in the Snoring Control Device industry to customers and expand the market sector. In recent years, the Snoring Control Device industry has offered some of the most significant advantages to daily needs sector. Major players in the Snoring Control Device market, including GlaxoSmithKline plc, Sleeping Well, LLC, ResMed, Apnea Sciences Corporation, MPowrx Health and Wellness Products, Somnomed Ltd, VitalSleep, and others, are investing in operations related to research and development in an effort to improve market demand.
GSK plc, a British multinational company engaged in biotechnology and pharmaceuticals, with its headquarters in London. GlaxoSmithKline plc is abbreviated as GSK plc. GSK was established in 2000 as a result of the union of Glaxo Wellcome and SmithKline Beecham, joining fellow pharmaceutical behemoths China Resources, Sinopharm, Johnson & Johnson, Pfizer, Roche, AbbVie, Novartis, Bayer, and Merck Sharp & Dohme. According to the 2022 Fortune 500, GSK is the tenth-largest pharmaceutical firm and is placed #294. In 2022, In a statement, the company said it would pay $1.9 billion ($55 per share) to purchase Sierra Oncology Inc. GSK said in May that it would buy Affinivax and its potential phase II 24-valent pneumococcal vaccine for up to $3.3 billion, bolstering its vaccine business.
ResMed Inc. is a manufacturer of medical equipment; it is situated in San Diego, California. It mainly offers medical devices that may be connected to the cloud for the treatment of respiratory disorders, such as COPD (chronic obstructive pulmonary disease), sleep apnea, and other conditions that affect the airways (such CPAP machines and masks). To help patients with Mamy-Diesel syndrome manage their respiratory difficulties, ResMed created countless ventilators and bilevel devices. In addition, ResMed offers software to non-hospital care facilities to facilitate care transfers for older citizens and their carers into and out of these facilities. In 2022, the business has production sites in Australia, Singapore, France, and the United States and conducts business in more than 140 nations.
Key Companies in the Snoring Control Device market include
Snoring Control Device Industry Developments
May 2023:Illusion Aligners unveiled a novel oral snoring device that is simple to use, convenient to wear, and provides customers with better sleep.
January 2021:GSK, PATH, and Bharat Biotech signed a product transfer contract about the malaria vaccine RTS, S/AS01E. According to the agreement, BBIL will take over vaccine production for the RTS, S antigen component and license full rights to the RTS, S/AS01 malaria vaccine. GSK will continue to make the vaccine's adjuvant (AS01E) and give it to BBIL when this arrangement expires.
December 2022:Mindray announced the launch of the mWear system, a wearable patient monitoring device, to monitor vital signs and provide efficient patient care and workflow.
| Report Attribute/Metric | Details |
| Market Size2022 | USD 0.35 Billion |
| Market Size 2023 | USD 0.39 Billion |
| Market Size2032 | USD 0.84 Billion |
| Compound Annual Growth Rate (CAGR) | 10.20% (2023-2032) |
| Base Year | 2022 |
| Market Forecast Period | 2023-2032 |
| Historical Data | 2018- 2022 |
| Market Forecast Units | Value (USD Billion) |
| Report Coverage | Revenue Forecast, Market Competitive Landscape, Growth Factors, and Trends |
| Segments Covered | Type, Distribution Channel, and Region |
| Geographies Covered | North America, Europe, AsiaPacific, and the Rest of the World |
| Countries Covered | The US, Canada, German, Brazil, China, Japan, India, Australia, South Korea, the UK, Italy, and Spain |
| Key Companies Profiled | Â GlaxoSmithKline plc, Sleeping Well, LLC, ResMed, Apnea Sciences Corporation, MPowrx Health and Wellness Products, Somnomed Ltd, VitalSleep, Airway Management Inc., TheraSnore, |
| Key Market Opportunities | To increase understanding of snoring and its associated health consequences, several public health programs have been established. |
| Key Market Dynamics | Increase in snoring and other sleep difficulties |
Frequently Asked Questions (FAQ) :
The Snoring Control Device market size was valued at USD 0.35 Billion in 2022.
The world's market is expected to continue to grow at a CAGR of 10.20% from 2023 to 2032.
The biggest share of the worldwide market was held by North America.
The main participants in the sector include GlaxoSmithKline plc, Sleeping Well, LLC, ResMed, Apnea Sciences Corporation, MPowrx Health and Wellness Products, Somnomed Ltd, VitalSleep, Airway Management Inc., TheraSnore.
The Oral Appliances/Mouthpieces category dominated the market in 2022.
The Online Stores had the largest share in the market.
Research Analyst Level I He is an extremely curious individual currently working in healthcare and medical devices domain. kinjoll is comfortably versed in data centric research backed by healthcare educational background. he leverages extensive data mining and analytics tools such as primary and secondary research, statistical analysis, machine learning, data modelling. his key role also involves technical sales support, client interaction and project management within the healthcare team. lastly, he showcases extensive affinity towards learning new skills and remain fascinated in implementing them.
Get in Touch
© 2024 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)
